KYORIN Holdings, Inc. (4569.T)
JPY 1600.0
(1.52%)
JPY 1600.0
(1.52%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 6.01 Billion JPY | 17.24% |
| 2022 | 5.12 Billion JPY | 2.32% |
| 2021 | 5 Billion JPY | -13.46% |
| 2020 | 5.78 Billion JPY | -22.88% |
| 2019 | 7.5 Billion JPY | -16.37% |
| 2018 | 8.97 Billion JPY | 1.7% |
| 2017 | 8.82 Billion JPY | -15.28% |
| 2016 | 10.41 Billion JPY | -46.97% |
| 2015 | 19.63 Billion JPY | 33.24% |
| 2014 | 14.73 Billion JPY | -16.3% |
| 2013 | 17.6 Billion JPY | -1.9% |
| 2012 | 17.94 Billion JPY | 24.09% |
| 2011 | 14.46 Billion JPY | -12.04% |
| 2010 | 16.44 Billion JPY | 24.0% |
| 2009 | 13.26 Billion JPY | 48.13% |
| 2008 | 8.95 Billion JPY | 43.21% |
| 2007 | 6.25 Billion JPY | -25.7% |
| 2006 | 8.41 Billion JPY | -6.41% |
| 2005 | 8.98 Billion JPY | 53.24% |
| 2004 | 5.86 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 1.15 Billion JPY | -25.61% |
| 2023 Q1 | 710 Million JPY | 68.65% |
| 2023 Q4 | 1.54 Billion JPY | -53.42% |
| 2023 FY | 6 Billion JPY | 17.24% |
| 2023 Q3 | 3.31 Billion JPY | 664.75% |
| 2023 Q2 | 434 Million JPY | -38.87% |
| 2022 Q3 | 3.92 Billion JPY | 1262.85% |
| 2022 Q4 | 421 Million JPY | -89.27% |
| 2022 Q1 | 489 Million JPY | -76.5% |
| 2022 Q2 | 288 Million JPY | -41.1% |
| 2022 FY | 5.12 Billion JPY | 2.32% |
| 2021 Q2 | 688 Million JPY | 191.01% |
| 2021 FY | 5 Billion JPY | -13.46% |
| 2021 Q3 | 2.99 Billion JPY | 335.17% |
| 2021 Q4 | 2.08 Billion JPY | -30.49% |
| 2021 Q1 | -756 Million JPY | -145.22% |
| 2020 Q1 | 2.01 Billion JPY | -9.77% |
| 2020 Q4 | 1.67 Billion JPY | -35.99% |
| 2020 Q2 | -512 Million JPY | -125.42% |
| 2020 Q3 | 2.61 Billion JPY | 610.16% |
| 2020 FY | 5.78 Billion JPY | -22.88% |
| 2019 Q4 | 2.23 Billion JPY | -50.27% |
| 2019 Q1 | 1.57 Billion JPY | -27.69% |
| 2019 Q2 | -792 Million JPY | -150.29% |
| 2019 Q3 | 4.48 Billion JPY | 666.67% |
| 2019 FY | 7.5 Billion JPY | -16.37% |
| 2018 Q1 | 1.32 Billion JPY | 29.79% |
| 2018 Q4 | 2.17 Billion JPY | -44.75% |
| 2018 Q2 | 1.53 Billion JPY | 16.06% |
| 2018 Q3 | 3.94 Billion JPY | 157.31% |
| 2018 FY | 8.97 Billion JPY | 1.7% |
| 2017 Q1 | 2.59 Billion JPY | -16.29% |
| 2017 Q4 | 1.01 Billion JPY | -84.01% |
| 2017 Q3 | 6.36 Billion JPY | 652.26% |
| 2017 Q2 | -1.15 Billion JPY | -144.39% |
| 2017 FY | 8.82 Billion JPY | -15.28% |
| 2016 Q1 | 3.24 Billion JPY | -34.73% |
| 2016 FY | 10.41 Billion JPY | -46.97% |
| 2016 Q3 | 3.65 Billion JPY | 771.12% |
| 2016 Q4 | 3.1 Billion JPY | -15.07% |
| 2016 Q2 | 419 Million JPY | -87.08% |
| 2015 FY | 19.63 Billion JPY | 33.24% |
| 2015 Q3 | 10.56 Billion JPY | 448.65% |
| 2015 Q2 | 1.92 Billion JPY | -11.37% |
| 2015 Q1 | 2.17 Billion JPY | -46.29% |
| 2015 Q4 | 4.97 Billion JPY | -52.97% |
| 2014 FY | 14.73 Billion JPY | -16.3% |
| 2014 Q2 | 1.01 Billion JPY | -71.69% |
| 2014 Q3 | 6.1 Billion JPY | 503.16% |
| 2014 Q4 | 4.04 Billion JPY | -33.72% |
| 2014 Q1 | 3.57 Billion JPY | -12.89% |
| 2013 Q3 | 7.29 Billion JPY | 317.05% |
| 2013 Q4 | 4.1 Billion JPY | -43.7% |
| 2013 Q2 | 1.74 Billion JPY | -60.85% |
| 2013 Q1 | 4.46 Billion JPY | 5.38% |
| 2013 FY | 17.6 Billion JPY | -1.9% |
| 2012 Q1 | 4.08 Billion JPY | 45.92% |
| 2012 FY | 17.94 Billion JPY | 24.09% |
| 2012 Q4 | 4.23 Billion JPY | -43.07% |
| 2012 Q3 | 7.44 Billion JPY | 239.97% |
| 2012 Q2 | 2.18 Billion JPY | -46.35% |
| 2011 FY | 14.46 Billion JPY | -12.04% |
| 2011 Q2 | 800 Million JPY | -80.49% |
| 2011 Q3 | 6.76 Billion JPY | 746.0% |
| 2011 Q4 | 2.79 Billion JPY | -58.69% |
| 2011 Q1 | 4.1 Billion JPY | -20.09% |
| 2010 Q2 | 1.98 Billion JPY | -10.47% |
| 2010 Q1 | 2.21 Billion JPY | 0.0% |
| 2010 FY | 16.44 Billion JPY | 24.0% |
| 2010 Q4 | 5.13 Billion JPY | -27.8% |
| 2010 Q3 | 7.1 Billion JPY | 258.22% |
| 2009 FY | 13.26 Billion JPY | 48.13% |
| 2009 Q2 | 1.41 Billion JPY | -55.32% |
| 2009 Q3 | 6.46 Billion JPY | 358.79% |
| 2009 Q4 | 2.21 Billion JPY | -65.74% |
| 2009 Q1 | 3.15 Billion JPY | -12.65% |
| 2008 FY | 8.95 Billion JPY | 43.21% |
| 2008 Q3 | 4.09 Billion JPY | 1564.63% |
| 2008 Q4 | 3.61 Billion JPY | -11.77% |
| 2008 Q2 | 246 Million JPY | 0.0% |
| 2007 FY | 6.25 Billion JPY | -25.7% |
| 2006 FY | 8.41 Billion JPY | -6.41% |
| 2005 FY | 8.98 Billion JPY | 53.24% |
| 2004 FY | 5.86 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 5.11 Billion JPY | -17.602% |
| Takeda Pharmaceutical Company Limited | 214.07 Billion JPY | 97.191% |
| Sumitomo Pharma Co., Ltd. | -354.19 Billion JPY | 101.698% |
| Shionogi & Co., Ltd. | 171.46 Billion JPY | 96.493% |
| Wakamoto Pharmaceutical Co.,Ltd. | -195.51 Million JPY | 3175.53% |
| Nippon Shinyaku Co., Ltd. | 31.38 Billion JPY | 80.842% |
| Kaken Pharmaceutical Co., Ltd. | 9.51 Billion JPY | 36.792% |
| Eisai Co., Ltd. | 53.4 Billion JPY | 88.741% |
| Morishita Jintan Co., Ltd. | 716 Million JPY | -739.804% |
| Hisamitsu Pharmaceutical Co., Inc. | 13.16 Billion JPY | 54.333% |
| Mochida Pharmaceutical Co., Ltd. | 5.8 Billion JPY | -3.619% |
| Fuso Pharmaceutical Industries,Ltd. | 1.96 Billion JPY | -206.161% |
| Nippon Chemiphar Co., Ltd. | -494 Million JPY | 1317.206% |
| Tsumura & Co. | 20.01 Billion JPY | 69.962% |
| Kissei Pharmaceutical Co., Ltd. | 4.01 Billion JPY | -49.689% |
| Torii Pharmaceutical Co., Ltd. | 5.03 Billion JPY | -19.4% |
| Towa Pharmaceutical Co., Ltd. | 17.64 Billion JPY | 65.928% |
| Fuji Pharma Co., Ltd. | 3.85 Billion JPY | -55.858% |
| Zeria Pharmaceutical Co., Ltd. | 9.71 Billion JPY | 38.117% |
| Taiko Pharmaceutical Co.,Ltd. | -3.07 Billion JPY | 295.291% |
| Daito Pharmaceutical Co.,Ltd. | 3.89 Billion JPY | -54.417% |
| SymBio Pharmaceuticals Limited | -811.66 Million JPY | 840.82% |
| MedRx Co., Ltd | -933 Million JPY | 744.48% |
| Mizuho Medy Co.,Ltd. | 5.15 Billion JPY | -16.712% |
| Solasia Pharma K.K. | -1.13 Billion JPY | 627.919% |
| Modalis Therapeutics Corporation | -2.37 Billion JPY | 353.713% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 6.5 Billion JPY | 7.492% |
| Sawai Group Holdings Co., Ltd. | 18.88 Billion JPY | 68.162% |
| Cyfuse Biomedical K.K. | -697.43 Million JPY | 962.157% |
| Toho Holdings Co., Ltd. | 19.33 Billion JPY | 68.895% |
| Koa Shoji Holdings Co.,Ltd. | 4.38 Billion JPY | -37.211% |